definiens: means [COMPANY] ’s proprietary cell therapyplatform used for the genetic editing of T - Cells ( including iPS Cell - derived T - Cells ), aﬃnityengineering of αβ Receptors of T - cells ( including iPS Cell - derived T - Cells, but not aﬃnityengineering of [COMPANY] - Provided αβ Receptors ), characterisation and testing of iPS Cells, including the insertion sites used by [COMPANY] to edit iPS Cells, constructs for enhancingthe safety, persistence, eﬃcacy or aﬃnity of T - Cells or T - Cell αβ Receptors ( other than anyGNE - Provided αβ Receptor ), integration and expression of Receptors ( other than any [COMPANY] - Provided αβ Receptor ), or safety testing of αβ Receptors ( other than any [COMPANY] - Provided αβReceptor ) and Cell Therapy products